About the Holding company

CMIC Ashfield is the result of a joint initiative by CMIC Holdings Plc. and Ashfield Healthcare, two major healthcare organizations providing a full breadth of capabilities on an international basis.

About CMIC Holdings Co., Ltd.

With the mission of contributing to the establishment of “Evidence-Based Medicine” and driven by its PVC (Pharmaceutical Value Creator) business model, CMIC Holdings contributes to increasing the added value of pharma companies throughout Asia, providing services to support the development, manufacturing, sales and marketing of pharmaceutical products and deliver health information to general consumers. For further information on CMIC Holdings, please visit

About CMIC Holdings Co., Ltd.

  • Established in 1992(Japan’s first CRO)
  • Largest CRO in Japan
  • Sales: 55,904 million yen
  • Operations in 7 countries
  • 5,900 professionals employed


About Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in providing outsourced healthcare services to pharmaceutical, device and biotech companies. The company has more than 7,000 employees, operates in 23 countries across Europe, North America, South America and Asia and works with more than 250 companies, including all of the world’s top 25 pharmaceutical companies. Its mission is to partner with its clients, improving lives by helping healthcare professionals and patients get the medicines, knowledge and support they need.
Ashfield’s provides contract sales teams, customer service reps, medical science liaison officers, remote detailing, nurse educators, medical information, healthcare communications, market access, market research, training, event management, digital, creative and pharmacovigilance services.
For more information, go to

About UDG

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering commercial, clinical, communications and packaging services to the healthcare industry, employing over 9,000 people with operations in 24 countries and delivering services in over 50 countries.
UDG Healthcare plc operates across two divisions: Ashfield and Sharp.
For more information, please go to http://www.udghealthcare.com/

About Ashfield

  • Established in 1997
  • Largest CSO in Europe
  • Sales: 104 million € in FY2016
  • Operations in 24 countries
  • 9,000 professionals employed


Together, across both UDG Healthcare and CMIC Ashfield, we are based in 24 countries and provide services in over 50 countries and areas.

About the Holding company


History of CSO business in the CMIC Group
UDG and Ashfield


CMIC Co. Ltd. is established


CMIC becomes Japan’s first CRO
(Contract Research Organization)


Ashfield Healthcare is established


CMIC establishes CMIC-CIM Co. Ltd. to train and develop MR and provide marketing support to Pharmaceutical Companies

Ashfield joins the United Drug group


CMIC-CIM changes its denomination to


With the acquisition of In2Focus, the new company Ashfield In2Focus becomes UK’s No.1 CSO

CMIC Group launched CSO services


CMIC-MPSS starts providing PMS monitoring services


SFE business is reinforced

CMIC-MPSS starts providing PMS monitoring services


Healthcare communications services are launched


Merges with Pharmexx (German CSO)

The SFE services are launched

CMIC Holdings and UDG Healthcare sign CSO business collaboration agreement


Trade name is changed with formation of a joint venture by CMIC Holdings and UDG Healthcare
MPSS and Ashfield officially launch the CMIC Ashfield joint venture


The Medical Affairs services are launched
PMS Monitoring services are transferred to CMIC PMS
The Contact Center services are launched